Elucidation of PEGylation Site with a Combined Approach of In-Source Fragmentation and CID MS/MS

被引:23
作者
Lu, Xiaojun [1 ]
Gough, P. Clayton [1 ]
DeFelippis, Michael R. [1 ]
Huang, Lihua [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Bioprod Res & Dev, Lilly Corp Ctr, Indianapolis, IN 46285 USA
关键词
POLY(ETHYLENE GLYCOL); POLYETHYLENE-GLYCOL; POSITIONAL ISOMERS; PEPTIDE; IDENTIFICATION; ATTACHMENT; IMMUNOGENICITY; CONJUGATION; PROTEINS; PEG;
D O I
10.1016/j.jasms.2010.01.011
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Poly(ethylene glycol) (PEG)ylation of peptides and proteins creates significant challenges for detailed structural characterization, such as PEG heterogeneity, site of addition and number of attached PEGylated moieties. Recently, we published a novel LC/MS methodology with a post-column addition of amines to obtain accurate masses of PEGylated peptides and proteins. The accurate masses can be used to assign the structures and number of attached PEGs [15], but the PEGylation site remains unclear in situations where multiple potential attachments are involved. Here, we present a methodology combining in-source fragmentation (ISF) with CID-MS/MS to elucidate the PEGylated sites in PEGylated products. All PEGylated samples, either prepared in acidic solution, or collected from a RP-HPLC stream, were first ionized via ISF to produce products containing small PEG fragment attachment, and then those fragment ions obtained were sequenced via CID MS/MS to deduce the PEGylation site. The methodology was successfully applied to PEGylated glucagon and IgG4 antibody light chain, which demonstrated that the small PEG fragments attached were stable during the CID activation. (J Am Soc Mass Spectrom 2010, 21, 810-818) (C) 2010 American Society for Mass Spectrometry
引用
收藏
页码:810 / 818
页数:9
相关论文
共 30 条
  • [1] ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582
  • [2] From production of peptides in milligram amounts for research to multi-tons quantities for drugs of the future
    Bruckdorfer, T
    Marder, O
    Albericio, F
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2004, 5 (01) : 29 - 43
  • [3] CARR A, 2009, P 57 ASMS C MASS SPE
  • [4] Long-acting growth hormones produced by conjugation with polyethylene glycol
    Clark, R
    Olson, K
    Fuh, G
    Marian, M
    Mortensen, D
    Teshima, F
    Chang, S
    Chu, H
    Mukku, V
    CanovaDavis, E
    Somer, T
    Cronin, M
    Winkler, M
    Wells, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (36) : 21969 - 21977
  • [5] Commentary - The origin of pegnology
    Davis, FF
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (04) : 457 - 458
  • [6] Isolation, structural characterization, and antiviral activity of positional isomers of monopegylated interferon α-2a (PEGASYS)
    Foser, S
    Schacher, A
    Weyer, KA
    Brugger, D
    Dietel, E
    Marti, S
    Schreitmüller, T
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 2003, 30 (01) : 78 - 87
  • [7] Effect of pegylation on pharmaceuticals
    Harris, JM
    Chess, RB
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (03) : 214 - 221
  • [8] Huang Lihua, 2005, V308, P411
  • [9] Characterization of Poly(ethylene glycol) and PEGylated Products by LC/MS with Postcolumn Addition of Amines
    Huang, Lihua
    Gough, P. Clayton
    DeFelippis, Michael R.
    [J]. ANALYTICAL CHEMISTRY, 2009, 81 (02) : 567 - 577
  • [10] Identification of the sites of deoxyhaemoglobin PEGylation
    Iafelice, Roberto
    Cristoni, Simone
    Caccia, Dario
    Russo, Rosaria
    Rossi-Bernardi, Luigi
    Lowe, Kenneth C.
    Perrella, Michele
    [J]. BIOCHEMICAL JOURNAL, 2007, 403 : 189 - 196